OS Therapies Incorporated (OSTX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | 8-K (2025-08-19) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-05-16) · 99.1 | ||
| 10-Q | Q1-2025 | — | ||
| 10-K | FY-2024 | 8-K (2025-03-31) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-15) · 99.1 | 8-K (2024-08-15) · 99.1 | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | — |
|
| Audit Information | — |
|
| Statements | ||
| Balance Sheets | ||
| Consolidated Balance Sheets | ||
| Balance Sheets (P) | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Statements of Operations | ||
| Consolidated Statements of Stockholders Deficit | ||
| Consolidated Statements of Stockholders Equity (deficit) (unaudited) | — |
|
| Statements of Operations (unaudited) (P) | — |
|
| Statements of Stockholders Deficit | ||
| Statements of Stockholders Equity (deficit) | — |
|
| Consolidated Statements of Cash Flows | ||
| Statements of Cash Flows | ||
| Statements of Cash Flows (P) | ||
| Notes | ||
| Commitments and Contingencies | ||
| Convertible Debt | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Equity | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Organization and Description of Business, Liquidity, and Risk Factors | ||
| Pay Vs Performance Disclosure | ||
| Redeemable Preferred Stock, Mezzainine Equity and Warrant Liability | ||
| Redeemable Preferred Stock, Mezzanine Equity and Warrant Liability | — |
|
| Related Party Transactions | ||
| Segment and Geographic Information | ||
| Significant Accounting Policies | ||
| Subsequent Events | ||
| Tedco Grant | ||